Non Opioid Pain Treatment Market Synopsis:
Non Opioid Pain Treatment Market Size Was Valued at USD 76.6 Billion in 2023, and is Projected to Reach USD 162.29 Billion by 2032, Growing at a CAGR of 8.7% From 2024-2032.
Non-Opioid Pain Treatment Market is a market of medical treatments for efficiently managing pain without the use of opioids, which has adverse effects on patients, such as dependency, misuse, or side effects. This market includes also many treatments like NSAIDs, anticonvulsants, antidepressants, muscle relaxants, and other pharmaceuticals, together with non-pharmacological approaches like physical therapy, acupuncture, TENS, and CBT approaches. Increasing consciousness of the dangers involved with opioids, acceptance by regulative bodies, and desire for more secure pain management techniques are key factors for the growth of this market, in applications that range from arthritis and peripheral neuropathy, to fibromyalgia and post-operative pain.
The growth of the industry can be explained by the growing investments of the market players in the development of new non-opioid analgesics, the activities of government and private organizations to introduce effective programs and inform the population about the existing treatment methods. The low hospitalization rate of the COVID-19 affected individuals and decline in the sales of non-opioid analgesics to treat the illness impacted the NSAID market to a moderate extent during the first stage of the pandemic. Due to a country-wide lockdown caused by the government to limit contact of infection, community mobility went down, and people had less need for drugs from the pharmacy, less surgeries at hospitals, meaning reduced use of the NSAIDs. The National Library of Medicine stated that the number of elective surgeries conducted in hospitals was decreased overall by approximately 91%. However, due to shortages of ibuprofen during the pandemic, more people used acetaminophen products like, Tylenol.
Contrary to the use of opioid analgesic products to treat pain, the market for non-opioid analgesic drugs presents great potential opportunities for growth. The problem of opioid drugs and the use of such substances as fentanyl and oxycodone threaten human health and welfare, and negatively affect a country’s economy. According to the CDC of the United States, it is believed that deaths due to opioid related overdoses stand at about 93,665 in the year 2021.
.webp)
Non Opioid Pain Treatment Market Trend Analysis:
An increasing number of cancer cases
-
It is expected that over the years this sector will expand because there is an enhanced incidence of breast, bowel, colorectal, and lung cancer. This is expected to work in the favour of the market as more patients come to realize that there is advanced, non-opioid heat patch currently available for use in addressing cancer pain in several countries. According to the WHO, in 2020, there will be 10 million people globally who will die from cancer. In the same year, for lung cancer it arrived at 1, 80,000 deaths, for liver cancer, 8, 30,000 deaths and for breast cancer more than 6, 85,000. This will show how the market will be affected by the soon,soon next rising incidence rate of cancer.
Chronic pain-related conditions are prevalent
-
The growth trend of non-opioid pain patch market in South Asia is expected due to improving incidence of chronic pain in India. Based from previous years, it is expected that there will be a trend where the government will invest on developing a health care system that is able to address illnesses with pain. For instance, a cross-sectional survey of chronic pain in Southeast Asia was conducted in December 2018 by Homi Bhabha National Institute and All India Institute of Medical Sciences. In all, 4326 Indian patients were assessed and 836 patients reported their discomfort by filling a questionnaire. The prevalence of the condition doubled in people aged 65 years and above and was higher among females (25.2%) than males. These number are expected to escalate in the near future, which would magnify Indias need for non-opioid heat patches.
Non Opioid Pain Treatment Market Segment Analysis:
Non Opioid Pain Treatment Market is Segmented on the basis of Drug Type, Indication, distribution Channel, and Region.
By Drug Type, Non-Steroidal Anti-Inflammatory Drugs segment is expected to dominate the market during the forecast period
-
This section highlights their projections and findings regarding the Leading Products Segments in the Non-Opioid Pain Treatment Market in the forecast period, based on their effectiveness, availability, and affordability of the most-used Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). During inflammation, the body forms enzymes that release inflammatory substances, and this is where NSAIDs intervene to help reduce all kinds of pain such as musculoskeletal and arthritic pain, headaches, and postoperative pain. Consequently, they are often recommended for both, short-term and long-term use in patients with chronic dams, as well as acute pains, providing an effective nociceptive pain relief, which does not entail dependency; this aspect is highly valued by both patients and clinicians, given current threats posed by opioids.
- This strong demand is reinforced by the fact that many NSAID products on the market may be purchased without a prescription. The forecasted superior NSAID market dominance is also attributed to ongoing development focused on improving and addressing the safety considerations and side effects including gastrointestinal and cardiovascular ones which some patients experience during the long term NSAID use. The modifications and modifications in NSAIDS, for example, enteric coatings and extended release forms are oriented to minimize side effects and make NSAIDs appropriate for the broad population.
By Indication, Chronic Pain segment expected to held the largest share
-
The Chronic Pain is expected to contribute largest chunk of share to the Non-Opioid Pain Treatment Market in the forecast period due to the rising incidence rate of chronic pain and requirement for long term effective pain management solutions that would not lead to addiction. Chronic pain which may embrace arthritis, neuropathic pain, back pain and fibromyalgia among others is a condition that cuts across millions of people all over the world and may at times need regular treatment to enhance the patient’s well-being. For chronic pain, patients prefer non-opioid medications such as NSAIDs, anticonvulsants, antidepressants, and other therapies than opioids as they do not lead to dependency or severe side effects as physical rehabilitation, CBT and others. This change is in compliance with different heath care scope policies and guidelines that disapprove the use of opioids in the management of long-term pains.
- The increasing growth of the chronic pain segment can also be attributed to innovations in treating chronic pain, the shift in focus on non-drug management treatments. More research is useful in improving care outcomes since it makes the healthcare providers to differentiate the management of patients by developing and implementing management pain plans that incorporates pharmacological and adjuvants therapies. Third, due to increased life expectancy, the number of ageing patients increases the demand for this segment because elderly patients, especially those with musculoskeletal pain, require pain relief often. Combined, these trends are increasingly positioning the Chronic Pain segment to account for a large market share, as care givers, patients, and governments seek for safer and non-opioid treatments for pain.
Non Opioid Pain Treatment Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
Geographically, North America is anticipated to remain the largest market for non-opioid pain treatment during the forecast period mainly due to a larger prevalence of chronic pain, improved healthcare facilities, and major inclination toward non-opioid treatment facilities rather than opioids. In recent years, the opioid epidemic in the United States has intensified the search for better analgesia, in turn demanding safer options. Actions from governmental organizations such as CDC and FDA have been encouraging and involved in the promotion of non-Opioid pain management products, which shall propel the market in future.
- Furthermore, the portion invested in research and innovation to provide better solutions to treatment in the case of pain management in the North American submarket strengthens the development of non-opioid options and makes the region a dominant one in this branch market segment. North America ’s dominance is also due to growing concern with opioid dependency among consumers and healthcare personnel coupled with a marked access to non-opioid treatment solutions. Emergency departments, acute care hospitals, specialist outpatient clinics, and clinics longitudinally in the United States and Canada have slowly started implementing non-pharmacological pain management care plans alongside pharmacologic approaches, including NSAIDs and antidepressants, as well as physical therapy, CBT, and other forms of treatment.
Active Key Players in the Non Opioid Pain Treatment Market:
- AstraZeneca plc (UK)
- AbbVie Inc. (USA)
- Bayer AG (Germany)
- Boehringer Ingelheim GmbH (Germany)
- Eli Lilly and Company (USA)
- Endo Pharmaceuticals (USA)
- GlaxoSmithKline plc (UK)
- Horizon Therapeutics plc (Ireland)
- Johnson & Johnson (USA)
- Merck & Co., Inc. (USA)
- Novartis AG (Switzerland)
- Pfizer Inc. (USA)
- Reckitt Benckiser Group plc (UK)
- Sanofi S.A. (France)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Other Active Players
|
Global Non Opioid Pain Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 76.6 Billion |
|
Forecast Period 2024-32 CAGR: |
8.7% |
Market Size in 2032: |
USD 162.29 Billion |
|
Segments Covered: |
By Drug Type |
|
|
|
By Indication |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Non Opioid Pain Treatment Market by Drug Type
4.1 Non Opioid Pain Treatment Market Snapshot and Growth Engine
4.2 Non Opioid Pain Treatment Market Overview
4.3 Non-Steroidal Anti-Inflammatory Drugs
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Non-Steroidal Anti-Inflammatory Drugs: Geographic Segmentation Analysis
4.4 Steriods
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Steriods: Geographic Segmentation Analysis
4.5 Analgesics
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Analgesics: Geographic Segmentation Analysis
4.6 Corticosteroids
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Corticosteroids: Geographic Segmentation Analysis
4.7 Others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Others: Geographic Segmentation Analysis
Chapter 5: Non Opioid Pain Treatment Market by Indication
5.1 Non Opioid Pain Treatment Market Snapshot and Growth Engine
5.2 Non Opioid Pain Treatment Market Overview
5.3 Musco Skeletal Disorders
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Musco Skeletal Disorders: Geographic Segmentation Analysis
5.4 Central Nervous System Disorders
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Central Nervous System Disorders: Geographic Segmentation Analysis
5.5 Traumatic Pain
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Traumatic Pain: Geographic Segmentation Analysis
5.6 Chronic Pain
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Chronic Pain: Geographic Segmentation Analysis
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation Analysis
Chapter 6: Non Opioid Pain Treatment Market by Distribution Channel
6.1 Non Opioid Pain Treatment Market Snapshot and Growth Engine
6.2 Non Opioid Pain Treatment Market Overview
6.3 Online Pharmacies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Online Pharmacies: Geographic Segmentation Analysis
6.4 Retail Pharmacies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Retail Pharmacies: Geographic Segmentation Analysis
6.5 Hospital Pharmacies
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Hospital Pharmacies: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Non Opioid Pain Treatment Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ABBVIE INC. (USA)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 ASTRAZENECA PLC (UK)
7.4 BAYER AG (GERMANY)
7.5 BOEHRINGER INGELHEIM GMBH (GERMANY)
7.6 ELI LILLY AND COMPANY (USA)
7.7 ENDO PHARMACEUTICALS (USA)
7.8 GLAXOSMITHKLINE PLC (UK)
7.9 HORIZON THERAPEUTICS PLC (IRELAND)
7.10 JOHNSON & JOHNSON (USA)
7.11 MERCK & CO. INC. (USA)
7.12 NOVARTIS AG (SWITZERLAND)
7.13 PFIZER INC. (USA)
7.14 RECKITT BENCKISER GROUP PLC (UK)
7.15 SANOFI S.A. (FRANCE)
7.16 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Non Opioid Pain Treatment Market By Region
8.1 Overview
8.2. North America Non Opioid Pain Treatment Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Drug Type
8.2.4.1 Non-Steroidal Anti-Inflammatory Drugs
8.2.4.2 Steriods
8.2.4.3 Analgesics
8.2.4.4 Corticosteroids
8.2.4.5 Others
8.2.5 Historic and Forecasted Market Size By Indication
8.2.5.1 Musco Skeletal Disorders
8.2.5.2 Central Nervous System Disorders
8.2.5.3 Traumatic Pain
8.2.5.4 Chronic Pain
8.2.5.5 Others
8.2.6 Historic and Forecasted Market Size By Distribution Channel
8.2.6.1 Online Pharmacies
8.2.6.2 Retail Pharmacies
8.2.6.3 Hospital Pharmacies
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Non Opioid Pain Treatment Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Drug Type
8.3.4.1 Non-Steroidal Anti-Inflammatory Drugs
8.3.4.2 Steriods
8.3.4.3 Analgesics
8.3.4.4 Corticosteroids
8.3.4.5 Others
8.3.5 Historic and Forecasted Market Size By Indication
8.3.5.1 Musco Skeletal Disorders
8.3.5.2 Central Nervous System Disorders
8.3.5.3 Traumatic Pain
8.3.5.4 Chronic Pain
8.3.5.5 Others
8.3.6 Historic and Forecasted Market Size By Distribution Channel
8.3.6.1 Online Pharmacies
8.3.6.2 Retail Pharmacies
8.3.6.3 Hospital Pharmacies
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Non Opioid Pain Treatment Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Drug Type
8.4.4.1 Non-Steroidal Anti-Inflammatory Drugs
8.4.4.2 Steriods
8.4.4.3 Analgesics
8.4.4.4 Corticosteroids
8.4.4.5 Others
8.4.5 Historic and Forecasted Market Size By Indication
8.4.5.1 Musco Skeletal Disorders
8.4.5.2 Central Nervous System Disorders
8.4.5.3 Traumatic Pain
8.4.5.4 Chronic Pain
8.4.5.5 Others
8.4.6 Historic and Forecasted Market Size By Distribution Channel
8.4.6.1 Online Pharmacies
8.4.6.2 Retail Pharmacies
8.4.6.3 Hospital Pharmacies
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Non Opioid Pain Treatment Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Drug Type
8.5.4.1 Non-Steroidal Anti-Inflammatory Drugs
8.5.4.2 Steriods
8.5.4.3 Analgesics
8.5.4.4 Corticosteroids
8.5.4.5 Others
8.5.5 Historic and Forecasted Market Size By Indication
8.5.5.1 Musco Skeletal Disorders
8.5.5.2 Central Nervous System Disorders
8.5.5.3 Traumatic Pain
8.5.5.4 Chronic Pain
8.5.5.5 Others
8.5.6 Historic and Forecasted Market Size By Distribution Channel
8.5.6.1 Online Pharmacies
8.5.6.2 Retail Pharmacies
8.5.6.3 Hospital Pharmacies
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Non Opioid Pain Treatment Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Drug Type
8.6.4.1 Non-Steroidal Anti-Inflammatory Drugs
8.6.4.2 Steriods
8.6.4.3 Analgesics
8.6.4.4 Corticosteroids
8.6.4.5 Others
8.6.5 Historic and Forecasted Market Size By Indication
8.6.5.1 Musco Skeletal Disorders
8.6.5.2 Central Nervous System Disorders
8.6.5.3 Traumatic Pain
8.6.5.4 Chronic Pain
8.6.5.5 Others
8.6.6 Historic and Forecasted Market Size By Distribution Channel
8.6.6.1 Online Pharmacies
8.6.6.2 Retail Pharmacies
8.6.6.3 Hospital Pharmacies
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Non Opioid Pain Treatment Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Drug Type
8.7.4.1 Non-Steroidal Anti-Inflammatory Drugs
8.7.4.2 Steriods
8.7.4.3 Analgesics
8.7.4.4 Corticosteroids
8.7.4.5 Others
8.7.5 Historic and Forecasted Market Size By Indication
8.7.5.1 Musco Skeletal Disorders
8.7.5.2 Central Nervous System Disorders
8.7.5.3 Traumatic Pain
8.7.5.4 Chronic Pain
8.7.5.5 Others
8.7.6 Historic and Forecasted Market Size By Distribution Channel
8.7.6.1 Online Pharmacies
8.7.6.2 Retail Pharmacies
8.7.6.3 Hospital Pharmacies
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Global Non Opioid Pain Treatment Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 76.6 Billion |
|
Forecast Period 2024-32 CAGR: |
8.7% |
Market Size in 2032: |
USD 162.29 Billion |
|
Segments Covered: |
By Drug Type |
|
|
|
By Indication |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
